扶正抗癌方联合化疗治疗胃癌效应观察
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

宿迁市科技项目(编号:Z201517)——扶正抗癌方治疗肝胃不和型胃癌临床疗效及机制研究


Clinical Curative Effect of Fuzhengkangai Decoction in Stomach Cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察扶正抗癌方联合西药治疗肝胃不和型胃癌疗效及机制。方法:将41例患者胃癌随机分为2组,均给予多西他赛40 mg/m2,第1,8天,静脉滴注1 h,并常规给予抗过敏预处理;奥沙利铂75 mg/m2,第1天,静脉滴注2 h;21 d为1个周期,共化疗2个周期。对照组21例在此基础上加服安慰剂;治疗组20例在上述治疗的基础上加用扶正抗癌方,治疗1个疗程(40 d)。判定疗效,观测临床症状、症状积分、不良反应,及免疫指标等。结果:观察组治疗总有效率显著高于对照组(P<0.05),免疫功能相关指标优于对照组(P<0.05),KPS评分(卡氏生活质量评分)显著优于对照组(P<0.05)。结论:扶正抗癌方联合西药治疗肝胃不和型胃癌疗效满意,无严重不良反应,可显著改善免疫功能及生存状况,值得推广应用。

    Abstract:

    To explore the clinical curative effect and mechanism of Fuzhengkangai decoction in stomach cancer.Methods:Fourty-one patients with gastric cancer were randomly divided into two groups, all given Docetaxel 40 mg/m2, on the first and the eighth day intravenous drip for1 h, and an allergy conventional pretreatment;Oxaliplatin 75 mg/m2, 1 day, intravenous drip for 2 h;21 d as a cycle, and there were two chemotherapy cycles. The 21 cases of Control group were provided with extra placebos; The 20 cases of Treatment group were on the basis of above treatment and with Fuzhengkangai decoction for 1 course (40 d). Curative effect, clinical symptoms, symptom integral, adverse reactions, and immune index, etc. were observed.Results:The total effective rate of the observation group was significantly higher than that of the control group (P<0.05), and the related parameters of immune function was better than that of control group (P<0.05), KPS score (carr’s quality of life score) also better (P<0.05).Conclusion:The consequence of Fuzhengkangai decoction combined with western medicine in stomach cancer which is due to liver-stomach disharmony is favorable with no serious adverse reactions, and can significantly improve the immune function and survival condition, whih is worthy of promotion.

    参考文献
    相似文献
    引证文献
引用本文

王小龙,徐彬,周雷,马俊杰,李智强,徐增柏.扶正抗癌方联合化疗治疗胃癌效应观察[J].世界中医药,2016,(12).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-11-28
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2017-02-17
  • 出版日期:
文章二维码